Статті в журналах з теми "Marine sarcoma"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Marine sarcoma".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Su, Bor-Chyuan, Giun-Yi Hung, Yun-Chieh Tu, Wei-Chen Yeh, Meng-Chieh Lin, and Jyh-Yih Chen. "Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization." Marine Drugs 19, no. 2 (February 5, 2021): 93. http://dx.doi.org/10.3390/md19020093.
Повний текст джерелаSu, Bor-Chyuan, Chao-Chin Li, Jiun-Lin Horng, and Jyh-Yih Chen. "Calcium-Dependent Calpain Activation-Mediated Mitochondrial Dysfunction and Oxidative Stress Are Required for Cytotoxicity of Epinecidin-1 in Human Synovial Sarcoma SW982 Cells." International Journal of Molecular Sciences 21, no. 6 (March 19, 2020): 2109. http://dx.doi.org/10.3390/ijms21062109.
Повний текст джерелаDelaloge, S., A. Yovine, A. Taamma, M. Riofrio, E. Brain, E. Raymond, P. Cottu, et al. "Ecteinascidin-743: A Marine-Derived Compound in Advanced, Pretreated Sarcoma Patients—Preliminary Evidence of Activity." Journal of Clinical Oncology 19, no. 5 (March 1, 2001): 1248–55. http://dx.doi.org/10.1200/jco.2001.19.5.1248.
Повний текст джерелаGarcia-Carbonero, R., J. G. Supko, J. Manola, M. V. Seiden, D. Harmon, D. P. Ryan, M. T. Quigley, et al. "Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy." Journal of Clinical Oncology 22, no. 8 (April 15, 2004): 1480–90. http://dx.doi.org/10.1200/jco.2004.02.098.
Повний текст джерелаAlthagbi, Hanan I., Walied M. Alarif, Khalid O. Al-Footy, and Ahmed Abdel-Lateff. "Marine-Derived Macrocyclic Alkaloids (MDMAs): Chemical and Biological Diversity." Marine Drugs 18, no. 7 (July 17, 2020): 368. http://dx.doi.org/10.3390/md18070368.
Повний текст джерелаMorgan, J. A., A. Le Cesne, S. Chawla, M. von Mehren, S. Schuetze, P. G. Casali, A. Nieto, Y. Elsayed, M. A. Izquierdo, and G. D. Demetri. "Randomized phase II study of trabectedin in patients with liposarcoma and leiomyosarcoma (L-sarcomas) after failure of prior anthracylines (A) and ifosfamide (I)." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 10060. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.10060.
Повний текст джерелаJimeno, Jose, Robert G. Maki, Paolo Casali, Glynn Faircloth, Nerea Martinez, Antonio Nieto, Salvador Cañigueral, and Kenneth Rinehart. "Therapeutic impact of ET-743 (Yondelis; trabectidin), a new marine-derived compound, in sarcoma." Current Opinion in Orthopaedics 14, no. 6 (December 2003): 419–28. http://dx.doi.org/10.1097/00001433-200312000-00011.
Повний текст джерелаPierce, J. H., and S. A. Aaronson. "Myeloid cell transformation by ras-containing murine sarcoma viruses." Molecular and Cellular Biology 5, no. 4 (April 1985): 667–74. http://dx.doi.org/10.1128/mcb.5.4.667-674.1985.
Повний текст джерелаPierce, J. H., and S. A. Aaronson. "Myeloid cell transformation by ras-containing murine sarcoma viruses." Molecular and Cellular Biology 5, no. 4 (April 1985): 667–74. http://dx.doi.org/10.1128/mcb.5.4.667.
Повний текст джерелаPecoraro, Camilla, Francesca Terrana, Giovanna Panzeca, Barbara Parrino, Stella Cascioferro, Patrizia Diana, Elisa Giovannetti, and Daniela Carbone. "Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development." Molecules 28, no. 18 (September 5, 2023): 6450. http://dx.doi.org/10.3390/molecules28186450.
Повний текст джерелаShamai, Sivan, and Ofer Merimsky. "Trabectedin for advanced soft tissue sarcoma: Ten-year real-life perspective." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 11060. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.11060.
Повний текст джерелаHayashi, Keita, Peter Walde, Tatsuhiko Miyazaki, Kenshi Sakayama, Atsushi Nakamura, Kenji Kameda, Seizo Masuda, Hiroshi Umakoshi, and Keiichi Kato. "Active Targeting to Osteosarcoma Cells and Apoptotic Cell Death Induction by the Novel Lectin Eucheuma serra Agglutinin Isolated from a Marine Red Alga." Journal of Drug Delivery 2012 (December 27, 2012): 1–11. http://dx.doi.org/10.1155/2012/842785.
Повний текст джерелаPonnusamy, Nirmaladevi, Rajasree Odumpatta, Pavithra Damodharan, and Mohanapriya Arumugam. "Computational investigation of marine bioactive compounds reveals frigocyclinone as a potent inhibitor of Kaposi’s Sarcoma Associated Herpesvirus (KSHV) targets." Biomedical & Pharmacology Journal 12, no. 3 (August 21, 2019): 1289–302. http://dx.doi.org/10.13005/bpj/1757.
Повний текст джерелаGordon, Erlinda Maria, Victoria S. Chua, Ted T. Kim, Neal Shiv Chawla, Don Arlen Brigham, Ishrat Bhuiyan, Mark Agulnik, Warren Allen Chow, and Sant P. Chawla. "A phase 2 study using ipilimumab, nivolumab, and trabectedin for previously untreated metastatic soft tissue sarcoma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 11562. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.11562.
Повний текст джерелаFares Amer, Nasrin, and Tal Luzzatto Knaan. "Natural Products of Marine Origin for the Treatment of Colorectal and Pancreatic Cancers: Mechanisms and Potential." International Journal of Molecular Sciences 23, no. 14 (July 21, 2022): 8048. http://dx.doi.org/10.3390/ijms23148048.
Повний текст джерелаSaada, Esma, Chahineze Rahal, Isabelle Ray Coquard, Antoine Italiano, Christine Chevreau, Nicolas Isambert, Binh Bui, et al. "Rechallenge with trabectedin in patients with locally advanced or metastatic soft tissue sarcoma following drug holiday: The experience of the French Sarcoma Group (FSG)." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 10062. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.10062.
Повний текст джерелаGrosso, F., G. D. Demetri, J. Y. Blay, I. Judson, A. Le Cesne, C. Spreafico, J. Jimeno, S. Pilotti, M. D’Incalci, and P. G. Casali. "Patterns of tumor response to trabectedin (ET743) in myxoid liposarcomas." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 9511. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.9511.
Повний текст джерелаDileo, P., F. Grosso, M. Casanova, J. Jimeno, S. Marsoni, R. Sanfilippo, M. Podda, S. Ferrari, R. Bertulli, and P. G. Casali. "Trabectedin (T) in metastatic Ewing's family tumors (EFT) patients (pts) progressing after standard chemotherapy." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 10040. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.10040.
Повний текст джерелаSouid, Soumaya, Dorra Aissaoui, Najet Srairi-Abid, and Khadija Essafi-Benkhadir. "Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response." Current Drug Targets 21, no. 10 (July 28, 2020): 996–1007. http://dx.doi.org/10.2174/1389450121666200128161733.
Повний текст джерелаSanfilippo, Roberta, Giacomo Giulio Baldi, Elena Fumagalli, Andrea Marrari, Rossella Bertulli, Elena Palassini, Silvia Stacchiotti, Michela Libertini, and Paolo Giovanni Casali. "Safety of trabectedin (T) in elderly patients (pts) with advanced soft tissue sarcoma (STS)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 10576. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.10576.
Повний текст джерелаDembitsky, Valery, Tatyana Gloriozova, and Vladimir Poroikov. "Antitumor Profile of Carbon-Bridged Steroids (CBS) and Triterpenoids." Marine Drugs 19, no. 6 (June 3, 2021): 324. http://dx.doi.org/10.3390/md19060324.
Повний текст джерелаMartinez-Trufero, Javier, Isabel Pajares, Alba Hernandez Garcia, Ana Cebollero, Lourdes Calera, and Antonio Anton. "Efficacy of trabectedin for advanced soft tissue sarcoma (ASTS): A retrospective single center analysis." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e21509-e21509. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e21509.
Повний текст джерелаLe Cesne, Axel, Isabelle Ray-Coquard, Florence Duffaud, Christine Chevreau, Nicolas Penel, Binh Bui, Sophie Piperno-Neumann, et al. "A large retrospective analysis of trabectedin in 885 patients with advanced soft tissue sarcoma." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 10563. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.10563.
Повний текст джерелаKampmann, Eric, Dominique Harnicek, Ana Sofia Cardoso Martins, Berina Eppink, Eike Gallmeier, Lars Lindner, Roland Kanaar, and Rolf D. Issels. "Heat-shock (H-S) and trabectedin efficacy in human soft-tissue sarcoma (STS) cells in vitro." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e13540-e13540. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13540.
Повний текст джерелаD'Incalci, Maurizio, Carlos Galmarini, Ines de la Riba Alvarez, Nadia Badri, and Patrick Schöffski. "Association between body weight and efficacy outcomes during trabectedin therapy for recurrent advanced soft tissue sarcoma (STS)." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 10047. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.10047.
Повний текст джерелаWang, Jun, Shihui Chen, Shiqiang Xu, Xing Yu, Dongqing Ma, Xiamin Hu, and Xiaolu Cao. "In Vivo Induction of Apoptosis by Fucoxanthin, a Marine Carotenoid, Associated with Down-Regulating STAT3/EGFR Signaling in Sarcoma 180 (S180) Xenografts-Bearing Mice." Marine Drugs 10, no. 12 (September 20, 2012): 2055–68. http://dx.doi.org/10.3390/md10092055.
Повний текст джерелаCioffi, A., A. LeCesne, J. Blay, S. Delaloge, A. Yovine, R. Maki, A. Nieto, J. J. Jiao, and G. D. Demetri. "Trabectedin phase II clinical trials: Pooled analysis of safety in patients with solid tumors." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e13510-e13510. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e13510.
Повний текст джерелаChawla, Sant P., Victoria S. Chua-Alcala, Katherine Kim, Nupur Assudani, Ahmad Al-Shihabi, Ania Moradkhani, Doris Quon, et al. "The SAINT: Initial results of a phase I/II study of safety/efficacy using safe amounts of ipilimumab, nivolumab, and trabectedin as first-line treatment of advanced soft tissue sarcoma." Journal of Clinical Oncology 37, no. 8_suppl (March 10, 2019): 22. http://dx.doi.org/10.1200/jco.2019.37.8_suppl.22.
Повний текст джерелаAljahdali, Mohammed Othman, Mohammad Habibur Rahman Molla, and Foysal Ahammad. "Compounds Identified from Marine Mangrove Plant (Avicennia alba) as Potential Antiviral Drug Candidates against WDSV, an In-Silico Approach." Marine Drugs 19, no. 5 (April 28, 2021): 253. http://dx.doi.org/10.3390/md19050253.
Повний текст джерелаPawłowska, Natalia, Anna Czajkowska, Anna Bielawska, and Krzysztof Bielawski. "Ecteinascidins – new antineoplastic drugs from the depths of the seas." Postępy Higieny i Medycyny Doświadczalnej 72 (December 13, 2018): 1062–72. http://dx.doi.org/10.5604/01.3001.0012.7873.
Повний текст джерелаGordon, Erlinda M., Nadezhda Omelchenko, Samantha Jeffrey, Vaishali Kumar, Neal S. Chawla, Mahesh Seetharam, Victoria Chua, et al. "Abstract CT287: LINNOVATE: A Phase 1/2 study of safety/efficacy using lurbinectedin, combined with ipilimumab, and nivolumab for advanced soft tissue sarcomas (NCT05876715)." Cancer Research 84, no. 7_Supplement (April 5, 2024): CT287. http://dx.doi.org/10.1158/1538-7445.am2024-ct287.
Повний текст джерелаBlay, J., M. von Mehren, B. L. Samuels, M. P. Fanucchi, I. L. Ray-Coquard, B. Buckley, L. Gilles, C. Lebedinsky, Y. A. Elsayed, and A. Le Cesne. "Combination of trabectedin (T) and doxorubicin (D) for the treatment of patients with soft tissue sarcoma (STS): Safety and efficacy analysis." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 10078. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.10078.
Повний текст джерелаXiao, Jin-Fen, Marina Broz, Roberta Piras, Kristin Ishaya, Emily Ko, and Jlenia Guarnerio. "Abstract 1364: Profiling tumor microenvironment for therapeutic intervention to soft-tissue sarcomas." Cancer Research 83, no. 7_Supplement (April 4, 2023): 1364. http://dx.doi.org/10.1158/1538-7445.am2023-1364.
Повний текст джерелаBehra, Biswadeep, S. Vairamuthu, Natesan Pazhanivel, Periyasamy Jalantha, and Ganne Venkata Sudhakar Rao. "Histological and Immunohistochemical Features of Pulmonary Metastatic Oral Melanoma in a Labrador dog." Indian Journal of Veterinary Sciences & Biotechnology 18, no. 5 (November 7, 2022): 119–22. http://dx.doi.org/10.48165/ijvsbt.18.5.24.
Повний текст джерелаGradl, Stefan, Sooncheol Lee, Martin Lange, Xiaoyun Wu, Silvia Goldoni, Timothy Lewis, Charlotte Kopitz, et al. "Abstract ND04: BAY 2666605: The first PDE3A-SLFN12 complex inducer for cancer therapy." Cancer Research 82, no. 12_Supplement (June 15, 2022): ND04. http://dx.doi.org/10.1158/1538-7445.am2022-nd04.
Повний текст джерелаLeone, Francesco, Caterina Peraldo-Neia, Giuliana Cavalloni, Marco Soster, Loretta Gammaitoni, Serena Marchiò, and Massimo Aglietta. "Preclinical evidence of ET-743 as a potential chemotherapy option for the treatment of biliary carcinoma." Journal of Clinical Oncology 31, no. 4_suppl (February 1, 2013): 193. http://dx.doi.org/10.1200/jco.2013.31.4_suppl.193.
Повний текст джерелаDel Campo, J., A. Roszak, T. Ciuleanu, M. Bidzinski, T. Hogberg, M. Wojtukienicz, K. Boman, A. Poveda, A. Westermann, and M. Izquierdo. "Phase II open label randomized study of trabectedin (T) given as two different dosing schedules in women with platinum-sensitive, recurrent ovarian carcinoma: Preliminary results." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 5031. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.5031.
Повний текст джерелаPeyraud, Florent, Jean-Philippe Guegan, Christophe Rey, Marina Pulido, Emmanuelle Bompas, Sophie Piperno-Neumann, Christine Chevreau, et al. "Abstract 2578: High regulatory T cells infiltrate within tertiary lymphoid structure restricts response to immune checkpoint blockers in sarcomas." Cancer Research 82, no. 12_Supplement (June 15, 2022): 2578. http://dx.doi.org/10.1158/1538-7445.am2022-2578.
Повний текст джерелаSalazar, R., B. Pardo, M. Majem, M. García, A. Montes, C. Cuadra, E. Ciruelos, H. Cortés-Funes, C. Lebedinsky, and L. Paz-Ares. "Phase I clinical and pharmacological trial of trabectedin (T) in 3 hour infusion every 3 weeks (3h/q3w) in patients with advanced cancer and hepatic function disorder." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 2080. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.2080.
Повний текст джерелаSinko, J., J. Rajchard, Z. Balounova, and L. Fikotova. " Biologically active substances from water invertebrates: a review." Veterinární Medicína 57, No. 4 (May 18, 2012): 177–84. http://dx.doi.org/10.17221/5914-vetmed.
Повний текст джерелаBroz, Marina T., Marco DeSimone, Emily Ko, Roberta Piras, and Jlenia Guarnerio. "Abstract A29: Uncovering transcriptional signatures of drug resistant tumor cells: Mechanisms of therapeutic resistance and opportunities for combination therapies." Cancer Immunology Research 10, no. 12_Supplement (December 1, 2022): A29. http://dx.doi.org/10.1158/2326-6074.tumimm22-a29.
Повний текст джерелаBanella, Cristina, Laura Zocca, Alessia Boaretto, Gianluca Mattei, Marina Mola, Lara Ballerini, Lorito Nicla, Annalisa Tondo та Maura Calvani. "Abstract A108: Metabolic oriented treatment: efficacy of sr59230a 𝜷3-adrenergic receptor antagonist, and sr plus buformin® in Ewing sarcoma". Molecular Cancer Therapeutics 22, № 12_Supplement (1 грудня 2023): A108. http://dx.doi.org/10.1158/1535-7163.targ-23-a108.
Повний текст джерелаBanella, Cristina, Francesco Carrozzo, Laura Zocca, Amada Pasha, Gianluca Mattei, Marina Mola, Lara Ballerini та ін. "Abstract 1787: The β3-adrenergic receptor as novel target of metabolic phenotype in Ewing sarcoma". Cancer Research 84, № 6_Supplement (22 березня 2024): 1787. http://dx.doi.org/10.1158/1538-7445.am2024-1787.
Повний текст джерелаZENETOS, A., S. KATSANEVAKIS, D. POURSANIDIS, F. CROCETTA, D. DAMALAS, G. APOSTOLOPOULOS, C. GRAVILI, E. VARDALA-THEODOROU, and M. MALAQUIAS. "Marine alien species in Greek Seas: Additions and amendments by 2010." Mediterranean Marine Science 12, no. 1 (March 11, 2011): 95. http://dx.doi.org/10.12681/mms.55.
Повний текст джерелаBroz, Marina, Emily Ko, Jinfen Xiao, Marco DeSimone, Roberta Piras, Kristin Ishaya, Xen Ping Hoi, and Jlenia Guarnerio. "Abstract 1255: Glucose dependent CD73+ CAFs enforce a tumor metabolic barrier that promotes T cell exclusion." Cancer Research 83, no. 7_Supplement (April 4, 2023): 1255. http://dx.doi.org/10.1158/1538-7445.am2023-1255.
Повний текст джерелаLee, Meng-Chou, Chin-Yi Huang, Chin-Ling Lai, Han-Yang Yeh, Jing Huang, Wei Qing Chloe Lung, Po-Tsang Lee, and Fan-Hua Nan. "Colaconema formosanum, Sarcodia suae, and Nostoc commune as Fermentation Substrates for Bioactive Substance Production." Fermentation 8, no. 7 (July 21, 2022): 343. http://dx.doi.org/10.3390/fermentation8070343.
Повний текст джерелаGolozubova, Julia Sergeevna, Lyubov Stepanovna Buzoleva, Elena Aleksandrovna Bogatyrenko, Alexandra Vyacheslavovna Kim, and Alena Igorevna Eskova. "Diversity of cultivated heterotrophic bacteria selected from surface waters of the Vostok Bay of the Japanese Sea." Samara Journal of Science 6, no. 4 (December 1, 2017): 32–35. http://dx.doi.org/10.17816/snv201764106.
Повний текст джерелаAtmaca, Harika, Emir Bozkurt, Burcu Cakar, Zeki Gokhan Surmeli, Selim Uzunoglu, Ruchan Uslu, and Burcak Karaca. "Trabectedin to induce mitochondrial membrane potential dissipation and reactive oxygen species generation in breast cancer cells." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e13580-e13580. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13580.
Повний текст джерелаTaamma, A., J. L. Misset, M. Riofrio, C. Guzman, E. Brain, L. Lopez Lazaro, H. Rosing, J. M. Jimeno, and E. Cvitkovic. "Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors." Journal of Clinical Oncology 19, no. 5 (March 1, 2001): 1256–65. http://dx.doi.org/10.1200/jco.2001.19.5.1256.
Повний текст джерелаGanapathi, Shireen S., Emma Wrenn, Nicolas Garcia, Neerja Katiyar, Aya Miyaki, Yuqi Kang, Marina Chan, Taran S. Gujral, and Elizabeth R. Lawlor. "Abstract 150: Transcriptional rewiring of BET inhibitor treated Ewing sarcoma cells augments their dependency on focal adhesion kinase." Cancer Research 84, no. 6_Supplement (March 22, 2024): 150. http://dx.doi.org/10.1158/1538-7445.am2024-150.
Повний текст джерела